China Regenerative Medicine International Balance Sheet Health
Financial Health criteria checks 4/6
China Regenerative Medicine International has a total shareholder equity of HK$25.1M and total debt of HK$41.2M, which brings its debt-to-equity ratio to 164%. Its total assets and total liabilities are HK$145.1M and HK$119.9M respectively.
Key information
164.0%
Debt to equity ratio
HK$41.21m
Debt
| Interest coverage ratio | n/a |
| Cash | HK$1.85m |
| Equity | HK$25.14m |
| Total liabilities | HK$119.94m |
| Total assets | HK$145.07m |
Recent financial health updates
These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively
Sep 21
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?
May 22Is China Regenerative Medicine International (HKG:8158) A Risky Investment?
Apr 13Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?
Sep 22Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?
Nov 24Recent updates
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding
Mar 05China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%
Jan 04These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively
Sep 21China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet
Jun 11Is China Regenerative Medicine International (HKG:8158) A Risky Investment?
May 22Is China Regenerative Medicine International (HKG:8158) A Risky Investment?
Apr 13Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?
Sep 22Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year
Mar 16What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?
Feb 08Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares
Dec 15
Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)
Nov 25Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?
Nov 24Financial Position Analysis
Short Term Liabilities: 8158's short term assets (HK$132.9M) exceed its short term liabilities (HK$98.2M).
Long Term Liabilities: 8158's short term assets (HK$132.9M) exceed its long term liabilities (HK$21.7M).
Debt to Equity History and Analysis
Debt Level: 8158's net debt to equity ratio (156.6%) is considered high.
Reducing Debt: 8158's debt to equity ratio has increased from 46% to 164% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 8158 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 8158 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 25.7% per year.